429 – A Novel Immunotherapeutic Platform for Amplifying HIV, CMV, or SARS-CoV-2-Specific T-Cell Responses
Background While adoptive cell transfer of HIV-specific T cells is a promising immunotherapy to provide a functional cure for HIV, its development and broader application is limited by the cost, logistical complexity, and variability of current methods for ex vivo expansion of HIV-specific T cells. To address these needs, we describe a novel modular and…